Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
Clinical trial NCT06327451 · RECRUITING
Trial details
- NCT number
- NCT06327451
- Sponsor
- Tianjin Medical University General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2026-02-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.